Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 404 followers
Latest posts
Last updated about 17 hours ago
Mundipharma, CorMedix eye antifungal expansion after Rezzayo trial win
about 17 hours ago
Mundipharma and CorMedix have announced a win for their antifungal drug Rezzayo...
Astellas counts on new medicines to offset projected Xtandi decline in fiscal 2026
about 21 hours ago
Compared with a 5.3% increase in Xtandi sales to $6 billion in...
Pfizer settles with 2 generic Vyndamax makers in latest twist to ATTR market: analysts
about 21 hours ago
Eleventh-hour settlements with two of the three generic drugmakers involved could bode...
Haleon nabs Google exec Richard Manso as US chief marketing officer
about 21 hours ago
Haleon, a healthcare consumer and OTC brand company, has hired Richard Manso...
Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon
about 21 hours ago
Already the largest biopharma company in India, generics powerhouse Sun Pharma has...
Ligand snaps up fellow biotech royalty aggregator Xoma for $739M
about 22 hours ago
After Xoma Royalty went on a dealmaking spree last year, the biotech...
FDA lambasts Incyte over ‘misleading’ Niktimvo claims
about 23 hours ago
The FDA has taken umbrage with certain Incyte promotional claims related to...
Accelerating clinical trials with precision logistics
4 days ago
Learn how Marken’s Laboratory Advantage improves speed, visibility and compliance to keep...
FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs
4 days ago
The FDA rejected two new products from AbbVie and Grace Therapeutics, citing...
Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval
4 days ago
After a series of setbacks for Sanofi’s tolebrutinib, the French company has...
Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
4 days ago
Daiichi Sankyo has postponed its annual report by two weeks, citing additional...
Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
4 days ago
An established sales force and payer authorization criteria will fuel a fast...